2m 2m 2m 2m 2m 2m 2m
- $155.4MMarket Cap
- -59.20%1-Year Change
- Insurance BrokersIndustry
SELECTQUOTE (SLQT)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 16
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Berman Tabacco Announces Investigation of SelectQuote, Inc. (NYSE:SLQT)
Law firm Berman Tabacco is investigating potential stockholder claims against SelectQuote for allegedly receiving illegal payments from Humana and Aetna to steer Medicare insurance customers, resulting in a 20% stock decline.
12/02/2025, 3:55 PM • GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of SelectQuote, Inc. Investors
The U.S. Department of Justice filed a false Claims Act complaint against SelectQuote, alleging illegal kickbacks and discriminatory practices in Medicare insurance plan referrals from 2016 to 2021, causing the company's stock to drop 19.24%.
10/09/2025, 3:45 PM • GlobeNewswire
Law Offices of Frank R. Cruz reminds investors of an upcoming lawsuit deadline against SelectQuote for alleged securities fraud involving illegal Medicare insurance kickbacks and misleading investors between September 2020 and May 2025.
10/09/2025, 12:00 PM • Benzinga
A class action lawsuit has been filed against SelectQuote alleging the company made false statements about its Medicare insurance plan referral practices, potentially violating federal securities laws during the period of September 2020 to May 2025.
10/09/2025, 12:00 PM • GlobeNewswire
SelectQuote is under investigation by the DOJ for allegedly steering Medicare Advantage customers toward high-commission insurance plans and accepting illegal kickbacks, leading to a securities class-action lawsuit and significant stock price decline.
10/08/2025, 6:35 PM • GlobeNewswire
The Schall Law Firm is pursuing a class action lawsuit against SelectQuote for allegedly misleading investors by directing Medicare beneficiaries to insurance plans based on kickbacks rather than customer suitability between September 2020 and May 2025.
10/07/2025, 7:08 AM • Benzinga
Law firm announces class action lawsuit against SelectQuote for allegedly misleading investors about Medicare insurance plan practices between September 2020 and May 2025, with stock price dropping 19.2% on May 1, 2025.
10/05/2025, 12:00 PM • GlobeNewswire
SelectQuote (SLQT) Faces Investor Lawsuit After DOJ Steps into Medicare Sales Probe – Hagens Berman
SelectQuote is under federal investigation for allegedly steering Medicare Advantage customers toward high-commission insurance plans and accepting illegal kickbacks, leading to a DOJ lawsuit and a securities class-action lawsuit by investors.
10/03/2025, 2:39 PM • GlobeNewswire
SelectQuote faces a class action lawsuit alleging illegal kickbacks and misleading Medicare beneficiaries by steering them to specific insurance plans for financial gain, resulting in a significant stock price drop.
10/01/2025, 10:11 PM • GlobeNewswire
Law firm Bragar Eagel & Squire filed a class action lawsuit against SelectQuote, alleging the company received illegal kickbacks from health insurers and steered Medicare beneficiaries to plans that compensated them most, regardless of plan quality.
09/29/2025, 5:28 PM • Benzinga
SelectQuote is facing a class action lawsuit alleging they made false and misleading statements about their Medicare Advantage plan comparisons, potentially accepting kickbacks from providers.
09/29/2025, 11:04 AM • Benzinga
Bernstein Liebhard LLP is reminding SelectQuote investors of an upcoming deadline for a securities fraud class action lawsuit alleging misrepresentations about the company's business practices, with potential legal action between September 9, 2020 and May 1, 2025.
09/29/2025, 9:19 AM • Benzinga
Rosen Law Firm alerts investors who purchased SelectQuote securities between September 2020 and May 2025 about an upcoming class action lawsuit deadline on October 10, 2025, alleging the company made false and misleading statements about its Medicare plan referral practices.
09/26/2025, 12:15 AM • GlobeNewswire
Rosen Law Firm is alerting SelectQuote investors about a potential securities class action lawsuit, claiming the company made false and misleading statements about its Medicare insurance plan referral practices between September 2020 and May 2025.
09/25/2025, 5:42 PM • Benzinga
A class action lawsuit alleges SelectQuote improperly directed Medicare beneficiaries to insurance plans based on compensation, potentially violating laws and regulations.
09/25/2025, 5:42 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/12/2026
Company Profile
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution and engagement platform that sells insurance policies and healthcare services in the United States. The company operates through three segments: Senior, Healthcare Services, and Life. It offers medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance-related products, as well as engages in lead generation business; term life, final expense, and other ancillary products; non-commercial auto and home, property, and casualty insurance products. The company also provides SelectRx, a patient-centered pharmacy; Healthcare Select, which uses data from personal health risk and lifestyle assessment; HomeTM (PCPH), an accredited pharmacy; SelectPatient Management (SPM), a platform that helps patients navigate their chronic conditions and manage them using a treatment plan; and individual automobile and homeowners' insurance. SelectQuote, Inc. was incorporated in 1999 and is headquartered in Overland Park, Kansas.
Key Executives
- Timothy Robert Danker
- Ryan Clement
- Robert Clay Grant
- William Thomas Grant
- Daniel A. Boulware
Current Ownership Distribution
- Mutual Funds2.1B (58.80%)
- Institutions1.4B (40.34%)
- Insiders30.8M (0.86%)
- Other0 (0.00%)